236 related articles for article (PubMed ID: 9021192)
1. Effects of benzoxazinorifamycin KRM-1648 on cytokine production at sites of Mycobacterium avium complex infection induced in mice.
Tomioka H; Sato K; Shimizu T; Sano C; Akaki T; Saito H; Fujii K; Hidaka T
Antimicrob Agents Chemother; 1997 Feb; 41(2):357-62. PubMed ID: 9021192
[TBL] [Abstract][Full Text] [Related]
2. Effects of the Chinese traditional medicine mao-bushi-saishin-to on therapeutic efficacy of a new benzoxazinorifamycin, KRM-1648, against Mycobacterium avium infection in mice.
Shimizu T; Tomioka H; Sato K; Sano C; Akaki T; Dekio S; Yamada Y; Kamei T; Shibata H; Higashi N
Antimicrob Agents Chemother; 1999 Mar; 43(3):514-9. PubMed ID: 10049260
[TBL] [Abstract][Full Text] [Related]
3. [Mechanism of bacterial regrowth at the sites of infection in Mycobacterium avium complex-infected mice during treatment with chemotherapeutic agents].
Sato K; Tomioka H; Maw WW; Saito H
Kekkaku; 1995 Dec; 70(12):673-8. PubMed ID: 8551714
[TBL] [Abstract][Full Text] [Related]
4. [Profiles of expression of the therapeutic efficacy of KRM-1648 in mice infected with Mycobacterium avium complex at different challenge doses].
Shimizu T; Ogasawara K; Sato K; Sano C; Tomioka H
Kekkaku; 2001 May; 76(5):413-8. PubMed ID: 11449696
[TBL] [Abstract][Full Text] [Related]
5. [Effects of secretory leukocyte protease inhibitor on the production of some cytokines and nitric oxide by murine peritoneal macrophages in response to lipopolysaccharide stimulation and M. avium complex infection].
Sano C; Shimizu T; Sato K; Ogasawara K; Tomioka H
Kekkaku; 1999 Jul; 74(7):563-70. PubMed ID: 10481411
[TBL] [Abstract][Full Text] [Related]
6. Effects of Yokuinin on the therapeutic efficacy of a new benzoxazinorifamycin KRM-1648 against Mycobacterium avium infection.
Shimizu T; Tomioka H; Sato K; Sano C; Yamada Y; Shibata H; Higashi N
Int J Antimicrob Agents; 1999 Jan; 11(1):69-74. PubMed ID: 10075281
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapeutic efficacy of a newly synthesized benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex infection induced in mice.
Tomioka H; Saito H; Sato K; Yamane T; Yamashita K; Hosoe K; Fujii K; Hidaka T
Antimicrob Agents Chemother; 1992 Feb; 36(2):387-93. PubMed ID: 1605603
[TBL] [Abstract][Full Text] [Related]
8. The role of tumour necrosis factor-alpha in combination with interferon-gamma or interleukin-1 in the induction of immunosuppressive macrophages because of Mycobacterium avium complex infection.
Tomioka H; Maw WW; Sato K; Saito H
Immunology; 1996 May; 88(1):61-7. PubMed ID: 8707352
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic effects of benzoxazinorifamycin KRM-1648 administered alone or in combination with glycyrrhizin against Mycobacterium avium complex infection in mice].
Shimizu T; Tomioka H; Sato K; Akaki T; Ogasawara K; Kawahara S
Kekkaku; 1999 Aug; 74(8):617-21. PubMed ID: 10487030
[TBL] [Abstract][Full Text] [Related]
10. [Effects of various steroidal and non-steroidal anti-inflammatory drugs on in-vitro IL-10 production of murine peritoneal macrophages infected with Mycobacterium avium complex].
Shimizu T; Sano C; Sato K; Tomioka H
Kansenshogaku Zasshi; 1997 Sep; 71(9):910-7. PubMed ID: 9339628
[TBL] [Abstract][Full Text] [Related]
11. The modulating effects of proinflammatory cytokines interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha), and immunoregulating cytokines IL-10 and transforming growth factor-beta (TGF-beta), on anti-microbial activity of murine peritoneal macrophages against Mycobacterium avium-intracellulare complex.
Sano C; Sato K; Shimizu T; Kajitani H; Kawauchi H; Tomioka H
Clin Exp Immunol; 1999 Mar; 115(3):435-42. PubMed ID: 10193415
[TBL] [Abstract][Full Text] [Related]
12. [In vitro antimicrobial activities of quinolones, rifamycins and macrolides against Mycobacterium tuberculosis and M.avium complex: attempt to establish new assay methods which accurately reflect therapeutic effects of test agents in vivo].
Sato K; Tomioka H
Kekkaku; 1999 Jan; 74(1):63-70. PubMed ID: 10067057
[TBL] [Abstract][Full Text] [Related]
13. [Effects of half-sized secretory leukocyte protease inhibitor and Chinese traditional medicines, yokuinin and mao-bushi-saishin-to, on therapeutic efficacies of benzoxazinorifamycin KRM-1648 against Mycobacterium avium complex infection induced in mice].
Sato K; Shimizu T; Tomioka H; Kawahara S
Kekkaku; 1998 Aug; 73(8):501-6. PubMed ID: 9780605
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of in vivo therapeutic efficacy of a new benzoxazinorifamycin, KRM-1648, in SCID mouse model for disseminated Mycobacterium avium complex infection.
Emori M; Tomioka H; Sato K; Saito H
Int J Antimicrob Agents; 1998 Apr; 10(1):59-65. PubMed ID: 9624545
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial activities of benzoxazinorifamycin (KRM-1648) and clarithromycin against Mycobacterium avium-intracellulare complex within murine peritoneal macrophages, human macrophage-like cells and human alveolar epithelial cells.
Sato K; Tomioka H
J Antimicrob Chemother; 1999 Mar; 43(3):351-7. PubMed ID: 10223590
[TBL] [Abstract][Full Text] [Related]
16. [Effects of the Chinese traditional medicines "mao-bushi-saishin-to" and "yokuinin" on the antimycobacterial activity of murine macrophages against Mycobacterium avium complex infection].
Shimizu T; Sano C; Akaki T; Ogasawara K; Sato K; Tomioka H
Kekkaku; 1999 Sep; 74(9):661-6. PubMed ID: 10535279
[TBL] [Abstract][Full Text] [Related]
17. [The expression of ICAM-1 on macrophages stimulated with Mycobacterium avium complex and its control by some regulatory cytokines].
Maw WW; Tomioka H; Sato K; Saito H
Kekkaku; 1996 Oct; 71(10):561-7. PubMed ID: 8936990
[TBL] [Abstract][Full Text] [Related]
18. [MICs and MBCs of levofloxacin, clarithromycin, and KRM-1648 for Mycobacterium tuberculosis and M. avium complex residing in MONO-MAC-6 human macrophage-like cell and A-549 human type II alveolar epithelial cell lines].
Sato K; Ogasawara K; Akaki T; Tomioka H
Kekkaku; 1999 Jul; 74(7):571-7. PubMed ID: 10481412
[TBL] [Abstract][Full Text] [Related]
19. Activities of the benzoxazinorifamycin KRM 1648 and ethambutol against Mycobacterium avium complex in vitro and in macrophages.
Inderlied CB; Barbara-Burnham L; Wu M; Young LS; Bermudez LE
Antimicrob Agents Chemother; 1994 Aug; 38(8):1838-43. PubMed ID: 7986017
[TBL] [Abstract][Full Text] [Related]
20. The role of tumor necrosis factor, interferon-gamma, transforming growth factor-beta, and nitric oxide in the expression of immunosuppressive functions of splenic macrophages induced by Mycobacterium avium complex infection.
Tomioka H; Sato K; Maw WW; Saito H
J Leukoc Biol; 1995 Dec; 58(6):704-12. PubMed ID: 7499969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
